Pedro Rodriguez Cutillas

Employment

• Instituto de Parasitología y Biomedicina "López - Neyra" Profresor de Investigación
  2025 - Present
• Barts Cancer Institute Professor of Cell Signalling & Proteomics
  2020 - 2025
• Kinomica Ltd Academic Founder
  2019 - Present
• Alan Turing Institute Turing Fellow
  2018 - 2023
• Barts Cancer Institute Reader in Cell Signalling & Proteomics
  2015 - 2020
• Barts Cancer Institute Senior Lecturer
  2013 - 2015
• MRC Clinical Sciences Centre Head of Proteomics
  2012 - 2013
• Activiomics Ltd Co-Founder and Non-Executive Director
  2011 - 2014
• Activiomics Ltd Co-Founder and Non-Executive Director
  2011 - 2014
• Barts Cancer Institute Senior Lecturer
  2010 - 2012
• Barts Cancer Institute Lecturer
  2007 - 2010
• Ludwig Institute for Cancer Research, UCL branch Postdoctoral scientist
  2006 - 2006
• University College London Postdoctoral scientist
  2003 - 2006

Education

• University College London PhD Biochemistry
  2000 - 2004
• King's College London BSc Biochemistry
  1997 - 2000

Projects & Funding

Projects & funding information is unavailable.

Publications (228)

• The AGO2 adaptor LIMD1 expands the functional and evolutionary reach of microRNA targeting
  Science Advances 2026 DOI: 10.1126/sciadv.aed6875
  +Save
• Surfaceome Capture by Multiplex Biotinylation Enables Enhanced Identification of Cell Surface Proteins by Mass Spectrometry
  Molecular & Cellular Proteomics 2026 DOI: 10.1016/j.mcpro.2026.101572
  +Save
• Quantitative phosphoproteomics uncovers the signalling dynamics of hallucinogenic psychedelics
  2025 DOI: 10.1101/2025.11.24.690190
  +Save
• HMMR has oncoprotein-like properties in neuroblastoma cells and high HMMR expression has independent prognostic potential in neuroblastomas
  Scientific Reports 2025 DOI: 10.1038/s41598-025-23141-5
  +Save
• Understanding the sources of performance in deep drug response models reveals insights and improvements
  Bioinformatics 2025 DOI: 10.1093/bioinformatics/btaf255
  +Save
• Maternal immune activation imprints translational dysregulation and differential MAP2 phosphorylation in descendant neural stem cells
  Molecular Psychiatry 2025 DOI: 10.1038/s41380-025-02905-5
  +Save
• High levels of DNA replication initiation factors indicate ATRi sensitivity via excessive origin firing
  2025 DOI: 10.1101/2025.02.27.640046
  +Save
• An AGO2 adaptor expands the functional and evolutionary reach of microRNA targeting
  Biorxiv 2025 DOI: 10.1101/2025.10.07.680889
  +Save
• DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes
  Leukemia 2025 DOI: 10.1038/s41375-025-02593-8
  +Save
• DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes
  Biorxiv 2025 DOI: 10.1101/2025.03.05.641116
  +Save